Rationale and design of the Post-MI FREEE trial: a randomized evaluation of first-dollar drug coverage for post-myocardial infarction secondary preventive therapies. [electronic resource]
Producer: 20080731Description: 31-6 p. digitalISSN:- 1097-6744
- Adrenergic beta-Antagonists -- economics
- Aged
- Angiotensin-Converting Enzyme Inhibitors -- economics
- Cardiovascular Agents -- economics
- Continuity of Patient Care -- economics
- Cost Sharing
- Drug Costs
- Evaluation Studies as Topic
- Female
- Humans
- Hydroxymethylglutaryl-CoA Reductase Inhibitors -- economics
- Insurance, Pharmaceutical Services -- economics
- Male
- Middle Aged
- Myocardial Infarction -- diagnosis
- Patient Compliance -- statistics & numerical data
- Patient Selection
- Risk Assessment
- Secondary Prevention
- Sensitivity and Specificity
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.